Pulse Investments Limited (JMSE:PULS)

CTI BioPharma Ratios and Metrics

Market cap in millions JMD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	6,066	9,784	18,199	28,831	28,440	21,200
Market Cap Growth	-55.50%	-46.24%	-36.88%	1.38%	34.15%	365.95%
Enterprise Value	6,820	10,482	18,685	29,216	28,735	21,250
Last Close Price	0.93	1.50	2.78	4.41	4.35	3.24
PE Ratio	-	18.02	12.71	16.14	19.36	25.23
PS Ratio	16.95	12.00	19.18	30.98	35.24	31.27
PB Ratio	0.62	1.06	2.08	3.87	5.09	5.19
P/TBV Ratio	0.63	1.07	2.10	3.92	5.18	5.31
P/FCF Ratio	-	-	63.47	267.13	43.69	182.30
P/OCF Ratio	-	-	63.09	234.06	43.64	179.36
EV/Sales Ratio	19.06	12.86	19.69	31.40	35.60	31.34
EV/EBITDA Ratio	-	46.34	29.38	43.47	67.53	72.59
EV/EBIT Ratio	-	47.07	29.58	43.85	68.02	73.33
EV/FCF Ratio	-28.07	-	65.17	270.70	44.15	182.74
Debt / Equity Ratio	0.08	0.09	0.08	0.09	0.08	0.06
Debt / EBITDA Ratio	-	3.47	1.13	0.94	1.04	0.85
Debt / FCF Ratio	-	-	2.52	5.86	0.68	2.15
Asset Turnover	0.03	0.07	0.09	0.12	0.14	0.16
Quick Ratio	0.45	0.19	1.00	2.34	0.14	3.02
Current Ratio	0.78	0.52	1.89	2.37	0.15	3.09
Return on Equity (ROE)	-4.17%	6.03%	17.69%	27.42%	30.36%	22.94%
Return on Assets (ROA)	-1.17%	1.20%	3.81%	5.13%	4.55%	4.33%
Return on Capital (ROIC)	-1.35%	1.43%	4.50%	5.91%	5.09%	4.74%
Return on Capital Employed (ROCE)	-	1.90%	5.60%	7.20%	6.60%	6.20%
Earnings Yield	-6.98%	5.55%	7.87%	6.20%	5.17%	3.96%
FCF Yield	-4.00%	-0.84%	1.58%	0.37%	2.29%	0.55%
Dividend Yield	-	-	0.18%	-	0.11%	0.15%
Payout Ratio	-	6.01%	-	-	2.22%	3.88%
Buyback Yield / Dilution	-5.92%	-	-	-	-	-
Total Shareholder Return	-	-	0.18%	-	0.11%	0.15%

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.